GLP-1 drugs: what South Dakota Medicaid paid

Q: Does a paid prescription mean South Dakota Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

South Dakota Medicaid shows a published payment figure for 4 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read South Dakota Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What South Dakota Medicaid’s payment record shows

In 2026Q1, the product South Dakota Medicaid paid for most often was Mounjaro®, at 2,260 prescriptions⁷ of the 3,794 to 3,929^7,13,19,25 across all 8 products, or 60 percent of the published count.

South Dakota Medicaid itself reimbursed at least $3,910,051 for these products in the quarter, about $1,035 per prescription. Pharmacies were paid $3,962,062 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,317.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what South Dakota Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, South Dakota Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What South Dakota Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what South Dakota Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Not published	Withheld	n/a	Not published	Not published	Not published
tirzepatideMounjaro®	Fee-for-service	2,260⁷	60%	$2,400,740	$2,439,627	$1,062
semaglutideWegovy®	Fee-for-service	at least 11¹³	<1%	$14,489	$14,489	$1,317
semaglutideOzempic®	Fee-for-service	1,402¹⁹	37%	$1,391,215	$1,402,366	$992
semaglutideRybelsus®	Fee-for-service	106²⁵	3%	$103,607	$105,580	$977
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Fee-for-service	Withheld	n/a	Not published	Not published	Not published

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 1,402 against 254. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 30.4 to 31.5 prescriptions per thousand people enrolled in South Dakota Medicaid, on an average of 124,684 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 10 of the 168 product-quarters it holds a row for here, which is 6 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by South Dakota Medicaid: no prescription was reported, and the reason is not published here.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether South Dakota Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what South Dakota Medicaid paid for each product, quarter by quarter

Prescriptions South Dakota Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter²No row	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable¹Withheld4 of 4 product codes withheld
tirzepatideMounjaro®range 337 to 2,260	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld3 of 3 product codes withheld	at least 44 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$41,012 paid	at least 99 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$94,715 paid	at least 205 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$198,826 paid	337 paid prescriptions in the quarter (2023Q3)¹⁰Count$330,940 paid	498 paid prescriptions in the quarter (2023Q4)¹⁰Count$487,654 paid	at least 717 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$724,736 paid	at least 843 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$850,076 paid	1,131 paid prescriptions in the quarter (2024Q3)⁹Count$1,138,195 paid	1,361 paid prescriptions in the quarter (2024Q4)⁹Count$1,389,287 paid	1,607 paid prescriptions in the quarter (2025Q1)⁸Count$1,633,943 paid	at least 1,746 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$1,766,599 paid	at least 1,901 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$1,941,082 paid	at least 2,232 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$2,318,925 paid	2,260 paid prescriptions in the quarter (2026Q1)⁷Count$2,400,740 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter¹⁴No row	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable¹⁴Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable¹⁴Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable¹⁴Withheld5 of 5 product codes withheld	at least 11 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$14,489 paid
semaglutideOzempic®range 254 to 1,730, down 183 on the quarter before	254 paid prescriptions in the quarter (2021Q1)²⁴Count$203,987 paid	303 paid prescriptions in the quarter (2021Q2)²⁴Count$255,409 paid	at least 361 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$281,634 paid	375 paid prescriptions in the quarter (2021Q4)²⁴Count$301,217 paid	491 paid prescriptions in the quarter (2022Q1)²³Count$403,177 paid	at least 594 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$504,280 paid	648 paid prescriptions in the quarter (2022Q3)²³Count$552,458 paid	759 paid prescriptions in the quarter (2022Q4)²³Count$645,498 paid	at least 902 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$800,341 paid	909 paid prescriptions in the quarter (2023Q2)²²Count$824,102 paid	at least 938 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$854,960 paid	at least 1,045 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$950,245 paid	1,251 paid prescriptions in the quarter (2024Q1)²¹Count$1,187,056 paid	at least 1,554 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$1,463,835 paid	1,657 paid prescriptions in the quarter (2024Q3)²¹Count$1,535,981 paid	1,721 paid prescriptions in the quarter (2024Q4)²¹Count$1,615,897 paid	at least 1,789 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$1,730,642 paid	1,730 paid prescriptions in the quarter (2025Q2)²⁰Count$1,667,954 paid	1,683 paid prescriptions in the quarter (2025Q3)²⁰Count$1,620,719 paid	1,585 paid prescriptions in the quarter (2025Q4)²⁰Count$1,526,687 paid	1,402 paid prescriptions in the quarter (2026Q1)¹⁹Count$1,391,215 paid
semaglutideRybelsus®range 85 to 118, down 12 on the quarter before	at least 15 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$11,939 paid	at least 12 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$10,336 paid	at least 34 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$28,670 paid	at least 19 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$15,746 paid	at least 65 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$57,757 paid	at least 67 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$55,879 paid	at least 47 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$40,677 paid	at least 67 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$57,142 paid	at least 91 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$75,245 paid	at least 66 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$56,454 paid	at least 68 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$61,799 paid	at least 82 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$74,538 paid	at least 109 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$98,397 paid	106 paid prescriptions in the quarter (2024Q2)²⁷Count$97,926 paid	101 paid prescriptions in the quarter (2024Q3)²⁷Count$95,450 paid	92 paid prescriptions in the quarter (2024Q4)²⁷Count$84,209 paid	85 paid prescriptions in the quarter (2025Q1)²⁶Count$80,321 paid	104 paid prescriptions in the quarter (2025Q2)²⁶Count$97,092 paid	116 paid prescriptions in the quarter (2025Q3)²⁶Count$107,965 paid	118 paid prescriptions in the quarter (2025Q4)²⁶Count$112,758 paid	106 paid prescriptions in the quarter (2026Q1)²⁵Count$103,607 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 34 to 94	94 paid prescriptions in the quarter (2021Q1)⁴²Count$75,673 paid	90 paid prescriptions in the quarter (2021Q2)⁴²Count$75,144 paid	90 paid prescriptions in the quarter (2021Q3)⁴²Count$75,346 paid	90 paid prescriptions in the quarter (2021Q4)⁴²Count$79,290 paid	91 paid prescriptions in the quarter (2022Q1)⁴¹Count$83,497 paid	81 paid prescriptions in the quarter (2022Q2)⁴¹Count$69,574 paid	84 paid prescriptions in the quarter (2022Q3)⁴¹Count$72,920 paid	69 paid prescriptions in the quarter (2022Q4)⁴¹Count$56,165 paid	71 paid prescriptions in the quarter (2023Q1)⁴⁰Count$59,026 paid	52 paid prescriptions in the quarter (2023Q2)⁴⁰Count$46,895 paid	56 paid prescriptions in the quarter (2023Q3)⁴⁰Count$46,810 paid	73 paid prescriptions in the quarter (2023Q4)⁴⁰Count$61,637 paid	73 paid prescriptions in the quarter (2024Q1)³⁹Count$52,909 paid	68 paid prescriptions in the quarter (2024Q2)³⁹Count$40,615 paid	34 paid prescriptions in the quarter (2024Q3)³⁹Count$22,080 paid	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³⁹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³⁷No row
liraglutideliraglutide (generic)range 30 to 44	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	30 paid prescriptions in the quarter (2024Q3)⁴⁵Count$17,386 paid	44 paid prescriptions in the quarter (2024Q4)⁴⁵Count$26,378 paid	at least 40 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$23,973 paid	at least 31 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$17,462 paid	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable⁴⁴Withheld6 of 6 product codes withheld	at least 11 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$5,202 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld7 of 7 product codes withheld

What this page cannot tell you

Whether South Dakota Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open South Dakota in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, SD
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, SD
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like ZEPBOUND%, state SD, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, SD
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like ZEPBOUND%, state SD, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, SD
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like ZEPBOUND%, state SD, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, SD
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like ZEPBOUND%, state SD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, SD
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like ZEPBOUND%, state SD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, SD
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "501"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, SD
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "520"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, SD
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "355"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, SD
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "121"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, SD
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "19"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, SD
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like MOUNJARO%, state SD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, SD
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 0.5", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, SD
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, SD
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like WEGOVY%, state SD, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, SD
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like WEGOVY%, state SD, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, SD
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like WEGOVY%, state SD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, SD
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like WEGOVY%, state SD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, SD
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "534"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, SD
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "649"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, SD
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "656"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, SD
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "444"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, SD
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "373"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, SD
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "208"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, SD
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, SD
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "52"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, SD
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "51"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, SD
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, SD
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "26"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, SD
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "19"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, SD
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like SAXENDA%, state SD, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, SD
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like SAXENDA%, state SD, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, SD
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like SAXENDA%, state SD, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, SD
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like SAXENDA%, state SD, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, SD
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like SAXENDA%, state SD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, SD
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like SAXENDA%, state SD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, SD
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like VICTOZA%, state SD, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, SD
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, SD
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "42"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, SD
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "46"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, SD
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2022", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "61"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, SD
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "64"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, SD
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state SD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SD", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, SD
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state SD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "29"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, SD
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state SD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, SD
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state SD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like LIRAGLUTID%, state SD, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, SD
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state SD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like LIRAGLUTID%, state SD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, SD
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state SD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SD", "product_name": "product_name like LIRAGLUTID%, state SD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 28 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 20 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean South Dakota Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.